Medicine
Micafungin 20 mg/mL powder for injection
Micafungin 20 mg/mL powder for injection is a generic prescription medicine for intravenous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Micafungin
- Brand
- Sold under the generic name
- Strength
- 20 mg/mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial, 10 vials, 20 vials and 11 more
- Manufacturers
- Zydus LifesciencesIndiaGlenmark PharmaceuticalsIndiaBioconIndiaSagent PharmaceuticalsMeitheal PharmaceuticalsQilu Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store the reconstituted product at 25°C (77°F) Store the diluted solution at 25°C (77°F) Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AX05 Micafungin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 June 2021
- Identifiers
- RxCUI 861379, 861383DailyMed set ID 653f8c75-b5b8-41ea-8b33-5baad1680bda, 29f17423-5787-47d0-a83b-bbdc0198fbfa, 72bc5dd6-6052-4483-9b13-afdeaaa8cc69 +4NDC 67184-0590, 70710-1725, 70771-1684 +4Application ANDA219273, ANDA215241, ANDA215381 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 5 mL in 1 vial | 70710-1725-1 | Zydus LifesciencesIndia | 20 August 2024 |
| 10 vial in 1 carton / 5 mL in 1 vial | 70710-1725-6 | Zydus LifesciencesIndia | 10 April 2023 |
| 1 vial in 1 carton / 5 mL in 1 vial | 70771-1684-1 | Zydus LifesciencesIndia | 20 August 2024 |
| 10 vial in 1 carton / 5 mL in 1 vial | 70771-1684-6 | Zydus LifesciencesIndia | 10 April 2023 |
| 10 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 70377-076-91 | BioconIndia | 1 June 2025 |
| 1 vial in 1 carton / 5 mL in 1 vial | 68462-772-01 | Glenmark PharmaceuticalsIndia | 30 June 2025 |
| 10 vial in 1 carton / 5 mL in 1 vial | 68462-772-10 | Glenmark PharmaceuticalsIndia | 30 June 2025 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 71288-029-11 | Meitheal Pharmaceuticals | 28 September 2022 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 71288-029-12 | Meitheal Pharmaceuticals | 1 November 2024 |
| 1 vial in 1 carton / 5 mL in 1 vial | 67184-0590-1 | Qilu Pharmaceutical | 3 April 2025 |
| 10 vial in 1 carton / 5 mL in 1 vial | 67184-0590-2 | Qilu Pharmaceutical | 3 April 2025 |
| 1 vial in 1 carton / 5 mL in 1 vial | 25021-191-10 | Sagent Pharmaceuticals | 15 June 2021 |
| 10 vial in 1 carton / 5 mL in 1 vial | 25021-191-11 | Sagent Pharmaceuticals | 15 September 2022 |
| 20 vial in 1 carton / 5 mL in 1 vial | 25021-191-12 | Sagent Pharmaceuticals | 1 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Micafungin
Clinical summary
Micafungin is an echinocandin antifungal indicated for treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult, among other approved uses. It is available as powder for injection and injection for intravenous use. MedsAcross supplies Micafungin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MicafunginFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Micafungin in Sodium Chloride prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
- Mycamine: European public assessment report (EPAR) · European Medicines Agency
Need Micafungin 20 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.